Pfizer says acquiring biotech firm Medivation for $14 billion
Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday.
Aug 22, 2016, 17:41 PM IST
Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday.
Aug 22, 2016, 17:41 PM IST